Daiichi Sankyo-Merck’s ‘guided-missile’ cancer drug meets main goal in late-stage trial

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

Approval Sought for Belantamab Mafodotin Combos for R/R Multiple Myeloma in Japan